Internal Medicine Alert – May 30, 2010
May 30, 2010
View Issues
-
Alcohol Consumption and Mortality in Patients with CVD
In patients with cardiovascular disease, light-to- moderate alcohol consumption is significantly associated with a lower incidence of cardiovascular and all-cause mortality. -
Another Argument for Moderation in All Things
Being overweight or obese increases the risk of cirrhosis. In this study, excess body weight contributed to almost 20% of the cirrhosis-related hospital admissions and deaths, while alcohol contributed to almost 50%. -
Silent Pulmonary Emboli in Patients with DVT: Time to Screen?
Asymptomatic pulmonary embolism is quite common among patients with deep venous thrombosis. In many instances in these patients, the pulmonary emboli are located within the central pulmonary arteries. -
How Much Physical Activity to Avoid Weight Gain?
Contrary to the current guidelines, in the long term, an average of approximately 60 min/day of moderate-intensity activity for women is required to be successful in maintaining a normal weight. -
Miconazole Buccal Tablets (Oravig™)
The FDA has approved a miconazole buccal tablet for the treatment of oropharyngeal candidiasis. This once-daily mucoadhesive buccal tablet provides slow release of the drug over the course of the day. The tablet is marketed by Strativa Pharmaceuticals as Oravig™. -
Clinical Briefs By Louis Kuritzky, MD
A well-established body of epidemiologic literature supports a continuous graded risk between systolic blood pressure (SBP) and CV risk. This relationship has held constant whether one considers office BP, home BP, or ambulatory blood pressure monitoring (ABPM).